All assets associated with the tag: LabCorp
At the requests of three companies, tax incentive plans have been terminated by the state of North Carolina - two of which are in the Triangle.
LabCorp early Thursday reported fourth-quarter financials that split the goalposts of analysts' expectations - beating on earnings but missing on revenue. However, its CEO described the quarter as demonstrating "strong underlying fundamentals."
Life science giant Labcorp will call its looming spinoff Fortrea, its focus being clinical trials around the world and with 19,000 employees.
Tom Pike, the former CEO of Quintiles when the life science giant merged with IMS seven years ago to form the global firm now known as Iqvia, is joining Labcorp to help lead a spinoff.
Labcorp on Thursday reported a third-quarter profit of $352.8 million yet its overall financials didn't meet Wall Street expectations. But CEO Adam Schechter said the company "made important strategic progress."
Following the transaction, expected to be completed in the second half of 2023, Labcorp will continue to be publicly traded on the New York Stock Exchange and expects the Clinical Development business to be publicly listed. Here's a detailed look at the global company's plans.
Labcorp's double-header of news early Thursday - dominated by the fact the company is going to split in two - also included quartertly financials with profits topping Wall Street expectations.
Life science giant Labcorp , which over the years has swollen into a global venture through mergers and acquisitions, is about to get smaller, disclosing plans today to spin off its Clinical Development business as a separate company.
Labcorp recently announced that it scored 100, the highest score possible, on the 2022 Disability Equality Index (DEI), a comprehensive benchmarking tool for measuring disability inclusion in the workplace.
How many times have you been stung or bitten by something, don't know what it was, and are concerned you may be at risk from an allergic reaction? Well, Labcorp has a new test to take the guess work out of stings and bites.
Labcorp is rolling out a new test that will allow doctors to "identify and verify" signs of neurogenerative disease such as Alzheimer's and Parkinson's, the North Carolina-based life science giant announced Wednesday.
At least two North Carolina bioscience companies are playing important roles in the monkeypox outbreak. Here's what's happening.
North Carolina-based Labcorp is responding to the growing number of monkeypox cases by launching a test to detect the virus. Two cases have been reported in North Carolina and more than 500 across the U.S., according to the Centers for Disease Control.
Labcorp is expanding its footprint in Japan, with a new facility underway in conjunction with Japanese partner BML that will add capabilities in the region.
Labcorp announced this week a new testing program that provides genomic insights for cancer patients that is sponsored by Eli Lilly and Company.
Labcorp announced today that the company has developed a test that can assist patients and their doctors in establishing care plan for melanoma.
With COVID-19 cases again on the rise and flu still a threat, Labcorp has received emergency use authorization from the Food and Drug Administration for a new combination at-home test kit that targets not only COVID-19 but infleunza and a respiratory virus that is a threat to children.
There is a new and convenient way for millions of individuals to assess whether they are at risk for developing diabetes. Labcorp (NYSE: LH), a leading global life sciences company, is making screening for diabetes easier with the launch of an at-home collection kit through Labcorp OnDemand.
Labcorp on Thursday reported first-quarter earnings of $491.6 million, and its top exec says he is pleased. Here's the latest.
Burlington-based Labcorp has partnered with Walgreens to make its Pixel by Labcorp COVID-19 test kit available in drugstores at no cost for people who meet clinical guidelines.
Global life science giant Labcorp has closed its office in Ukraine's capital city and is monitoring its ongoing operations in Russia on a "case by case basis," the company says.
Labcorp completed the acquisition of an an emerging cancer genomics company and says that the $450 million deal helps the company expand its oncology portfolio.
Laboratory Corp. of America Holdings (LH) beat the Street with its latest financials reported early Thursday. And its top exec was upbeat about the report.
Labcorp launched a new product, Labcorp On Demand, noting that patients can now perform a variety of on-demand services from home.
Global life science giant Labcorp says it will acquire an emerging cancer genomics company in a deal worth $450 million now with the possibility of another $125 million going to its shareholders if benchmarks are met. Here are the details.
